Cognipride M 1mg/500mg Tablet
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Cognipride M 1mg/500mg Tablet
Diabetease Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetease Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, and tremors. To mitigate this, maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Cognipride M 1mg/500mg Tablet
Managing Type 2 Diabetes
Major Benefits of Cognipride M 1mg/500mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Cognipride M 1mg/500mg Tablet with a meal.
Common Side effects of Cognipride M 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Cognipride M 1mg/500mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Cognipride M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume with food.
How Cognipride M 1mg/500mg Tablet works:
Cognipride M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Cognipride M 1mg/500mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Cognipride M 1mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Cognipride M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Cognipride M 1mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Cognipride M 1mg/500mg Tablets. Consult a physician. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cognipride M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Cognipride M 1mg/500mg Tablet :
Should you forget a Cognipride M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cognipride M 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



